Journals / Respiratory Case Reports / 2016 / Cilt: 5 - Sayı: 2

Attention to Pheochromocytoma History: Lung Metastasis after Nine Years

Dokuz Yıl Sonra A_kciğer Metastazı: Feokromasitoma Oyküsüne Dikkat

Pages
81–84
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The case is presented due to its rarity with respect to the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A pheochromocytoma is a rare tumor arising from the adrenal medulla chromaffin cells with a malignancy rate of 10%.
📊
Key Findings & Data:A 55-year-old male was admitted to our clinic with complaints of fever, night sweats, and cough.
💡
Conclusion & Impact:The case is presented due to its rarity with respect to the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A pheochromocytoma is a rare tumor arising from the adrenal medulla chromaffin cells with a malignancy rate of 10%. Metastasis can occur years later, even in the presence of benign histopathological findings. A 55-year-old male was admitted to our clinic with complaints of fever, night sweats, and cough. His physical examination findings were normal. He had hypertension, diabetes mellitus, and coronary artery disease and he never smoked. Radiological examination revealed extended, multiple, well-defined, extended bilateral nodular and mass lesions. Transthoracic needle aspiration lung biopsy was performed and the biopsy result was reported as a pheochromocytoma metastasis. Due to extended lymph node and bone metastasis, he was referred to the oncology department. He died in the second year of the diagnosis. The case is presented due to its rarity with respect to the literature.

Özet

Feokromositoma, nadir görülen, adrenal medülladaki kromaffin hücrelerden kaynaklanan bir tümördür ve %10 oranında malign karakterlidir. Histopatolojik bulgular benign olsa da yıllar sonra metastaza rastlanabilir. Elli beş yaşında erkek hasta ateş ve öksürük şikâyetleri ile kliniğimize başvurdu. Genel durumu iyi, fizik muayene bulguları normaldi. Hipertansiyon, diabetes mellitus ve koroner arter hastalığı bulunmaktaydı. Hiç sigara içmemişti. Radyolojik görüntülemesinde her iki akciğerde, yaygın, nodüler ve kitlesel lezyonlar saptandı. Transtorasik iğne aspirasyon biyopsisi uygulandı ve feokromasitoma metastazı tanısı konuldu. Yaygın lenf nodu ve kemik metastazları da saptanan ve lezyonları rezektabl olmayan hasta onkolojiye yönlendirildi. Tanının ikinci yılında eksitus oldu. Olgu nadir görülmesi nedeniyle literatürler eşliğinde sunuldu.

🔖

Cite This Article

AKYIL, F. T., AKSOY, E., ÖZTÜRK, A., AKTAŞ, O., SEVİM, T. (2016). Attention to Pheochromocytoma History: Lung Metastasis after Nine Years. Respiratory Case Reports, Cilt: 5 - Sayı: 2, 81–84. https://ajindex.com/articles/302501

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Francis IR, Korobkin M. Pheochromocytoma. Radiol Clin North Am 1996; 34:1101-12
  2. Kawashima A, Sandler CM, Fishman EK, Charnsangavej C, Yasumori K, Honda H, et al. Spectrum of CT findings in nonmalignant disease of the adrenal gland. Radiographics 1998; 18:393-412. [CrossRef] 3. Goldstein RE, O'Neill JA Jr, Holcomb GW 3rd, Morgan WM 3rd, Neblett WW 3rd, Oates JA, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg 1999; 229:755-64. [CrossRef] 4. Pattarino F, Bouloux PM. The diagnosis of malignancy in phaeochromocytoma. Clin Endocrinol (Oxf). 1996; 44:239-41. [CrossRef] 5. Jimenez C, Rohren E, Habra MA, Rich T, Jimenez P, Ayala-Ramirez M, et al. Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma. Curr Oncol Rep 2013; 15:356-71. [CrossRef] 6. Querol Ripoll R, del Olmo García MI, Cámara Gómez R, Merino-Torres JF. Diffuse alveolar hemorrhage as first manifestation of a pheochromocytoma. Arch Bronconeumol. 2014; 50:412-3. [CrossRef] 7. Nam AS, Koizumi JH, Giorgadze T. Cytologic diagnosis of adrenal oncocytic pheochromocytoma in a lung cancer patient: Report of a case and review of the literature. Cytojournal 2015; 25:5. [CrossRef] 8. Tischler AS. Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med 2008; 132:1272-84. [CrossRef] 9. Bravo EL. Pheochromocytoma: new concepts and future trends. Kidney Int 1991; 40:544-56. [CrossRef] 10. Plouin PF, Chatellier G, Fofol I, Corvol P. Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension 1997; 29:1133-9. [CrossRef] 11. Choi WS, Park JY, Roh MS, Choi PJ. Malignant pheochromocytoma with lung metastasis after right adrenalectomy for pheochromocytoma eleven years ago. J Thorac Dis 2015; 7:E37-42. [CrossRef] 12. Park J, Song C, Park M, Yoo S, Park SJ, Hong S, et al. Predictive characteristics of malignant pheochromocytoma. Korean J Urol 2011; 52:241-6. [CrossRef] 13. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium, October 2005. Nat Clin Pract Endocrinol Metab 2007; 3:92-102. [CrossRef] 14. Keiser HR, Goldstein DS, Wade JL, Douglas FL, Averbuch SD. Treatment of malignant pheochromocytoma with combination chemotherapy. Hypertension 1985; 7:18- 24. [CrossRef] 15. Huang H, Abraham J, Hung E, Averbuch S, Merino M, Steinberg SM, et al. Treatment of malignant